Prosecution Insights
Last updated: November 04, 2026

Pikavation Therapeutics Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Pikavation Therapeutics Inc. is navigating the patent process with 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This singular focus suggests a streamlined prosecution strategy where resources are directed toward a specific intellectual property asset. The presence of 1 distinct examiner and 1 distinct art unit indicates that the company's current interactions with the USPTO are centralized, requiring a targeted approach to examiner engagement.

The busiest examiner assigned to the portfolio is ROMERO, KRISTEN WANG, who currently handles 1 pending office action. Since this examiner is responsible for the entirety of the company's pending actions, the prosecution success for this portfolio is currently tied to the specific feedback and requirements of ROMERO, KRISTEN WANG. This lack of examiner variety means the company cannot compare prosecution experiences across different individuals at this stage.

For a practitioner, the concentration in 1 distinct art unit and 1 distinct examiner simplifies the monitoring of deadlines and procedural requirements. However, it also means that any single office action carries significant weight for the overall portfolio health. The company must ensure that its responses are precisely tailored to the expectations of the assigned examiner to maintain progress in the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROMERO, KRISTEN WANG 1 69.8% +30.8%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18843508 PI3Ka INHIBITORS ROMERO, KRISTEN WANG —

Top Art Units

Art UnitApps
1624 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18843508 PI3Ka INHIBITORS ROMERO, KRISTEN WANG 1624 §112 Non-Final OA — Pending Sep 03, 2024

Managing Pikavation Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Pikavation Therapeutics Inc. have?

Pikavation Therapeutics Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Pikavation Therapeutics Inc. applications?

Kristen Wang Romero has the most, with 1 of Pikavation Therapeutics Inc.'s pending office actions.

What technology area are Pikavation Therapeutics Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month